Collateral Good Ventures

Collateral Good Ventures is a technology-focused venture capital firm founded in 2022 by molecular and cell biologist Dr Regina Hecker and serial entrepreneur and investor Michael Kleindl. The founders and team of Collateral Good Ventures feel responsible for contributing with their means (human and capital) to help the world eat better and mitigate climate change.

Collateral Good Ventures is dedicated to collaborating and supporting visionary business leaders who are ambitious and focused on how their business can be a positive force for stakeholders, communities and nature as a whole, companies that do “collateral good”, i.e. providing for their stakeholders while intrinsically contributing to social and environmental impact. Each opportunity has to have the potential to generate significant returns on capital and impact.

The underlying mission of the managed funds is to support and promote a positive, measurable social and global environmental impact alongside a significant financial return. The main focus areas are plant-based and novel ingredients, cellular agriculture (clean meat), food waste, food as medicine, personal nutrition and sustainable packaging.

The firm has committed that all strategies follow Art 9 under the EU Sustainable Finance Disclosure Regulation (SFDR).

Collateral Good Ventures, established in 2022 and headquartered in Switzerland, Europe., specializes in Early Stage Venture, Seed investments across Information Technology, Waste Management, Recycling, Nanotechnology, Venture Capital, Finance, Food and Beverage, Financial Services, FinTech, Wealth Management. Their recent investments include Polytag, Nfinite Nanotech, MaRS Investment Accelerator Fund, FTW Ventures, Republic capital. The highest investment round they participated in was $3.5B. Among their most notable exits are Polytag and Nfinite Nanotech. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.